drugset / Trial / NCT00841776

Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne

NCT00841776

Phase 4 Completed 54 enrolled Stiefel, a GSK Company GlaxoSmithKline · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of the study is to determine the development of microbial resistance when using one of two topical acne therapies for the treatment of facial acne vulgaris.

Timeline

Start
2007-08
Primary completion
2008-11
Completion
2009-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzoyl Peroxide Other / unclassified 5 % Topical
Subject Clindamycin Unknown 1 % Topical
Subject Clindamycin Unknown 1.2 % Topical
Subject Tretinoin Small molecule 0.025 % Topical

Indications